Summary
The efficacy and safety of leflunomide (LEF) in the treatment of rheumatoid arthritis (RA) were evaluated and the comparison with methotrexate’s (MTX’s) was performed in a 12-week, single-blind, randomized, parallel trial for treating 81 patients with RA. There were 56 cases in LEF group and 25 cases in MTX group. The dose of LEF was 20 mg per day and MTX 15 mg per week. All patients took oxaproxin simultaneously at the 4th to 6th week after the trail. The results showed that the general effective rate and notable effective rate were 94. 64 % and 73. 21 % in LEF group, 72 % and 44 % in MTX group, respectively, with the differences being statistically significant between the two groups (P<0. 05). LEF and oxaprozin could obviously improve the symptoms, signs and joint functions. The incidence of side reactions was lower in LEF group (17. 86 %) than in MTX group (40. 00 %,P<0. 05). LEF had a good therapeutic effect for RA, especially for refractory RA and had slight side reactions, and could be regarded as a superior immunosuppressive agent used in the treatment of RA and other connective tissue diseases.
Similar content being viewed by others
References
Herrman M, Frangou C G, Kirschbaum Bet al. Cell cycle control of the de novo pyrimidine synthesis inhibitor leflunomide through the P53 and p21WAF-l pathways. ACR Poster Session, 1997, abstract: 875
Amett F C, Edworthy S, Block D Aet al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rherm, 1988, 31(3): 315
Barlett R R. Leflunomide, an immunorestoring drug for the therapy autoimmune disorders, especially rheumatoid. Curr Opin Rheu, 1997, 9: 410
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yonghong, H., Shenghao, T. & Peilin, L. A randomized, controlled, single-blind trial of leflunomide in the treatment of rheumatoid arthritis. Current Medical Science 21, 72–74 (2001). https://doi.org/10.1007/BF02888043
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02888043